SlideShare une entreprise Scribd logo
1  sur  15
Télécharger pour lire hors ligne
The antiplatelet effect of aspirin
is reduced by proton pump
inhibitors in patients with
coronary artery disease
Heart 2010;96:368-71
Presented by :
DR AFIA SALEEM
Introduction
Aspirin is the mainstay of secondary
antithrombotic treatment
Aspirin treatment carries a risk of
dyspepsia and upper gastrointestinal
bleeding
Often combined with PPIS
PPIs exert their antacid effect by inhibiting the H+/K+exchanging ATPase of the gastric parietal
cells
Raising intragastric PH

Under physiologic acidic conditions,asprin is
absorbed in lipid state by passive diffusion across
membrane
Increased PH cause reduction
in
Lipophilicity of aspirin

Compromises bioavailability and
Efficacy of Aspirin

Soluble serum P-selectin (sP-selectin) is regarded a
marker of platelet activation.
TxB2 is regarded as the most specific test for
measuring the inhibitory effect of aspirin on platelets
Objectives
The main purpose of this study was to investigate
whether patients with coronary artery disease (CAD)
treated with PPI had a reduced platelet response
aspirin, as shown by increased residual platelet
aggregation and platelet activation, compared with
patients with CAD not taking PPIs
Study population
Patients 418 stable patients with CAD, 54 of whom
were treated with PPIs. All patients were treated with
non-enteric coated aspirin 75 mg/day and received
no other antithrombotic drugs .

Study Design
Case control study
INCLUSION CRITERIA
Patients ≥18 years of age with angiographically verified CAD receiving
low-dose (75 mg) non-enteric coated aspirin treatment were included in
the study

EXCLUSION CRITERIA
. 1. aspirin intolerance,
2 .any acute or chronic disease (apart from CAD),
3. use of anticoagulants or any drugs known to affect platelet function
(including clopidogrel and non-steroidal anti-inflammatory drugs),
4. Pregnancy
5, gastrointestinal bleeding within the past month
6, platelet count <120×109/l
7. any ischaemic event or revascularisation procedures (percutaneous
coronary intervention or coronary artery bypass grafting) within the
previous 12 months
. 8 inability to give informed consent
Main outcome measures
Platelet aggregation was measured by
multiplate((Dynabyte, Munich, Germany)
whole blood aggregometry induced by
arachidonic acid 1 .0 mmol/l and expressed
as Area under aggregation
curve(aggregation units *min)
Platelet activation was assessed by soluble
serum P- selectin.
Compliance was confirmed by serum
thromboxane B2 levels.
antiplatelet effect of aspirin
antiplatelet effect of aspirin
antiplatelet effect of aspirin
Platelet aggregation assessed by Multiplate
Platelet activation assessed by sP-selectin
Effects on S-TxB2 Levels
(Compliance).
Subjects

S-TxB2 levels

Geometric mean

Range(ng/ml)
Healthy subjects

327+/-123

-

No PPI with Aspirin

0.04-18.18

0.96(95%CI 0.88 to
1.05)

PPI with Aspirin

0.84-1.01

1.29(95%CI 0.96 to
1.72)
Conclusion
Patients with CAD treated with PPIs had a reduced
response to aspirin, as shown by increased residual
platelet aggregation and platelet activation, compared
with patients with CAD not taking PPIs. Concomitant
use of aspirin and PPIs might leave patients at an
increased risk of thrombotic events. These findings
may affect the clinical practice of antithrombotic
treatment. In view of the widespread use of PPIs, a
randomised double-blind crossover study (PPI vs
placebo + aspirin) is needed to explore further the
inhibitory effect of PPIs on aspirin.

Contenu connexe

Tendances (20)

Antiplatelet Drugs
Antiplatelet DrugsAntiplatelet Drugs
Antiplatelet Drugs
 
Pharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugsPharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugs
 
Fibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolyticsFibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolytics
 
Calcium channel blockers nikku
Calcium channel blockers nikkuCalcium channel blockers nikku
Calcium channel blockers nikku
 
Angiotensin receptor blockers
Angiotensin receptor blockersAngiotensin receptor blockers
Angiotensin receptor blockers
 
Fibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolyticsFibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolytics
 
Sulfonylureas
SulfonylureasSulfonylureas
Sulfonylureas
 
Nonsteroidal anti inflammatory drugs (NSAIDS)
Nonsteroidal anti inflammatory drugs (NSAIDS)Nonsteroidal anti inflammatory drugs (NSAIDS)
Nonsteroidal anti inflammatory drugs (NSAIDS)
 
Pharmacology of Antiplatelet drugs
Pharmacology of Antiplatelet drugsPharmacology of Antiplatelet drugs
Pharmacology of Antiplatelet drugs
 
Insulin pharmacology
Insulin pharmacologyInsulin pharmacology
Insulin pharmacology
 
Plasma volume expanders
Plasma volume expandersPlasma volume expanders
Plasma volume expanders
 
Woods Anticoag Antianem 09
Woods Anticoag Antianem 09Woods Anticoag Antianem 09
Woods Anticoag Antianem 09
 
Anticoagulants
AnticoagulantsAnticoagulants
Anticoagulants
 
Anticoagulants
AnticoagulantsAnticoagulants
Anticoagulants
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
 
Drugs for Congestive Heart Failure
Drugs for Congestive Heart FailureDrugs for Congestive Heart Failure
Drugs for Congestive Heart Failure
 
H2 antagonist and ppi
H2 antagonist and ppiH2 antagonist and ppi
H2 antagonist and ppi
 
Coagualnts and Anticoagulant
Coagualnts and Anticoagulant Coagualnts and Anticoagulant
Coagualnts and Anticoagulant
 
NSAID'S --ASPIRIN
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRIN
 
ORAL HYPOGLYCEMIC AGENTS
ORAL HYPOGLYCEMIC AGENTS ORAL HYPOGLYCEMIC AGENTS
ORAL HYPOGLYCEMIC AGENTS
 

En vedette

Guidelines for the management of severely acute malnourished children
Guidelines for the management of severely acute malnourished childrenGuidelines for the management of severely acute malnourished children
Guidelines for the management of severely acute malnourished childrenSM Lalon
 
Dissociative disorders case histories prof. fareed minhas
Dissociative disorders case histories prof. fareed minhasDissociative disorders case histories prof. fareed minhas
Dissociative disorders case histories prof. fareed minhasRawalpindi Medical College
 
Management of dissociate disorders prof. fareed minhas
Management of dissociate disorders prof. fareed minhasManagement of dissociate disorders prof. fareed minhas
Management of dissociate disorders prof. fareed minhasRawalpindi Medical College
 

En vedette (20)

Hypertension
HypertensionHypertension
Hypertension
 
Rheumatoid arthritis 2
Rheumatoid arthritis 2Rheumatoid arthritis 2
Rheumatoid arthritis 2
 
Hepatitis b,c, &d
Hepatitis b,c, &dHepatitis b,c, &d
Hepatitis b,c, &d
 
Malabsorption
Malabsorption Malabsorption
Malabsorption
 
Management of malnutrition
Management of malnutritionManagement of malnutrition
Management of malnutrition
 
Nephrotic syndrome.
Nephrotic syndrome.Nephrotic syndrome.
Nephrotic syndrome.
 
Renal disorders in pregnancy
Renal disorders in pregnancyRenal disorders in pregnancy
Renal disorders in pregnancy
 
Guidelines for the management of severely acute malnourished children
Guidelines for the management of severely acute malnourished childrenGuidelines for the management of severely acute malnourished children
Guidelines for the management of severely acute malnourished children
 
Lectures on demo
Lectures on demoLectures on demo
Lectures on demo
 
Child psychiatry prof. fareed minhas
Child psychiatry prof. fareed minhasChild psychiatry prof. fareed minhas
Child psychiatry prof. fareed minhas
 
Dissociative disorders case histories prof. fareed minhas
Dissociative disorders case histories prof. fareed minhasDissociative disorders case histories prof. fareed minhas
Dissociative disorders case histories prof. fareed minhas
 
Green house effect
Green house effectGreen house effect
Green house effect
 
Right bundle branch block
Right bundle branch blockRight bundle branch block
Right bundle branch block
 
Infective endocarditis-1
Infective endocarditis-1Infective endocarditis-1
Infective endocarditis-1
 
Dementia prof. fareed minhas
Dementia prof. fareed minhasDementia prof. fareed minhas
Dementia prof. fareed minhas
 
Research hmis
Research hmisResearch hmis
Research hmis
 
Tb
TbTb
Tb
 
Management of dissociate disorders prof. fareed minhas
Management of dissociate disorders prof. fareed minhasManagement of dissociate disorders prof. fareed minhas
Management of dissociate disorders prof. fareed minhas
 
Cns infections
Cns infectionsCns infections
Cns infections
 
Vascular system
Vascular systemVascular system
Vascular system
 

Similaire à antiplatelet effect of aspirin

Recent Advancements in the treatment of Hypertension.
Recent Advancements  in the treatment of Hypertension.Recent Advancements  in the treatment of Hypertension.
Recent Advancements in the treatment of Hypertension.Akshata Darandale
 
News on intra-abdominal hypertension - focus on fluids and hemodyknamics
News on intra-abdominal hypertension - focus on fluids and hemodyknamicsNews on intra-abdominal hypertension - focus on fluids and hemodyknamics
News on intra-abdominal hypertension - focus on fluids and hemodyknamicsInternational Fluid Academy
 
Mims cardiology research paper
Mims cardiology research paperMims cardiology research paper
Mims cardiology research paperMIMS HOSPITAL
 
Lipid management in peripheral artrerial disease .slides
Lipid management in peripheral artrerial disease .slidesLipid management in peripheral artrerial disease .slides
Lipid management in peripheral artrerial disease .slidesashwani mehta
 
CME Of CorbisT _PJMT_RLMT 2.pptx
CME Of CorbisT _PJMT_RLMT 2.pptxCME Of CorbisT _PJMT_RLMT 2.pptx
CME Of CorbisT _PJMT_RLMT 2.pptxVAIBHAVBHASTANA
 
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...cacao83
 
Journal club: The Fluid Debate in ICU
Journal club: The Fluid Debate in ICUJournal club: The Fluid Debate in ICU
Journal club: The Fluid Debate in ICUMustahsin Malik
 
Intradialytic hypotension & Its Managemnet
 Intradialytic hypotension & Its Managemnet Intradialytic hypotension & Its Managemnet
Intradialytic hypotension & Its ManagemnetDr Ashutosh Ojha
 
Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...
Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...
Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...wackysavior4064
 
Novel approaches in Lipid Management
Novel approaches in Lipid ManagementNovel approaches in Lipid Management
Novel approaches in Lipid ManagementShashikiran Umakanth
 
Cilnidipine in Renoprotection.pptx
Cilnidipine in Renoprotection.pptxCilnidipine in Renoprotection.pptx
Cilnidipine in Renoprotection.pptxParikshitMishra15
 

Similaire à antiplatelet effect of aspirin (20)

Recent Advancements in the treatment of Hypertension.
Recent Advancements  in the treatment of Hypertension.Recent Advancements  in the treatment of Hypertension.
Recent Advancements in the treatment of Hypertension.
 
International Journal of Clinical & Experimental Hypertension
International Journal of Clinical & Experimental HypertensionInternational Journal of Clinical & Experimental Hypertension
International Journal of Clinical & Experimental Hypertension
 
Pablo avanzas novedades farmacologia en intervencionismo
Pablo avanzas   novedades farmacologia en intervencionismoPablo avanzas   novedades farmacologia en intervencionismo
Pablo avanzas novedades farmacologia en intervencionismo
 
News on intra-abdominal hypertension - focus on fluids and hemodyknamics
News on intra-abdominal hypertension - focus on fluids and hemodyknamicsNews on intra-abdominal hypertension - focus on fluids and hemodyknamics
News on intra-abdominal hypertension - focus on fluids and hemodyknamics
 
Mims cardiology research paper
Mims cardiology research paperMims cardiology research paper
Mims cardiology research paper
 
Cruz C, Cruz LS Nephron Clinic Pract
Cruz C, Cruz LS Nephron Clinic PractCruz C, Cruz LS Nephron Clinic Pract
Cruz C, Cruz LS Nephron Clinic Pract
 
Lipid management in peripheral artrerial disease .slides
Lipid management in peripheral artrerial disease .slidesLipid management in peripheral artrerial disease .slides
Lipid management in peripheral artrerial disease .slides
 
PAH management
PAH managementPAH management
PAH management
 
CME Of CorbisT _PJMT_RLMT 2.pptx
CME Of CorbisT _PJMT_RLMT 2.pptxCME Of CorbisT _PJMT_RLMT 2.pptx
CME Of CorbisT _PJMT_RLMT 2.pptx
 
Artist trial
Artist trialArtist trial
Artist trial
 
Nrcardio.2014.104
Nrcardio.2014.104Nrcardio.2014.104
Nrcardio.2014.104
 
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
 
Pcsk 9 inhibitors
Pcsk 9 inhibitorsPcsk 9 inhibitors
Pcsk 9 inhibitors
 
Journal club: The Fluid Debate in ICU
Journal club: The Fluid Debate in ICUJournal club: The Fluid Debate in ICU
Journal club: The Fluid Debate in ICU
 
magnetically.pptx
magnetically.pptxmagnetically.pptx
magnetically.pptx
 
Intradialytic hypotension & Its Managemnet
 Intradialytic hypotension & Its Managemnet Intradialytic hypotension & Its Managemnet
Intradialytic hypotension & Its Managemnet
 
Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...
Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...
Emerging MRA-Based Treatments for End-Stage Renal Disease (ESRD) Patients on ...
 
Novel approaches in Lipid Management
Novel approaches in Lipid ManagementNovel approaches in Lipid Management
Novel approaches in Lipid Management
 
Cilnidipine in Renoprotection.pptx
Cilnidipine in Renoprotection.pptxCilnidipine in Renoprotection.pptx
Cilnidipine in Renoprotection.pptx
 
Bhnt
BhntBhnt
Bhnt
 

Plus de Rawalpindi Medical College (20)

Pertussis
PertussisPertussis
Pertussis
 
Symptomtology of cardiovascular diseases
Symptomtology of cardiovascular diseasesSymptomtology of cardiovascular diseases
Symptomtology of cardiovascular diseases
 
Symptomatology-GIT-1
Symptomatology-GIT-1Symptomatology-GIT-1
Symptomatology-GIT-1
 
Symptomatology-GIT
Symptomatology-GITSymptomatology-GIT
Symptomatology-GIT
 
Symptomalogy in RENAL impairement
Symptomalogy in RENAL impairementSymptomalogy in RENAL impairement
Symptomalogy in RENAL impairement
 
History taking
History takingHistory taking
History taking
 
Right and left ventricular hypertrophy
Right and left ventricular hypertrophyRight and left ventricular hypertrophy
Right and left ventricular hypertrophy
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Supraventricular tachyarrythmias
Supraventricular tachyarrythmiasSupraventricular tachyarrythmias
Supraventricular tachyarrythmias
 
Supraventricular tacchycardias
Supraventricular tacchycardias Supraventricular tacchycardias
Supraventricular tacchycardias
 
Skin-
Skin-Skin-
Skin-
 
Skin
Skin  Skin
Skin
 
Sick sinus syndrome-2
Sick sinus syndrome-2Sick sinus syndrome-2
Sick sinus syndrome-2
 
Sick sinus syndrome
Sick sinus syndrome Sick sinus syndrome
Sick sinus syndrome
 
X rays
X raysX rays
X rays
 
Ventricular arrhythmias
Ventricular arrhythmias Ventricular arrhythmias
Ventricular arrhythmias
 
Ventricular tachyarrhythmias
Ventricular tachyarrhythmias Ventricular tachyarrhythmias
Ventricular tachyarrhythmias
 
Resuscitation enc-3
Resuscitation enc-3Resuscitation enc-3
Resuscitation enc-3
 
Rbbb final
Rbbb finalRbbb final
Rbbb final
 
Polymyalgia rheumatica
Polymyalgia rheumaticaPolymyalgia rheumatica
Polymyalgia rheumatica
 

Dernier

5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...CaraSkikne1
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxKatherine Villaluna
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphNetziValdelomar1
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17Celine George
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17Celine George
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptxmary850239
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxEduSkills OECD
 

Dernier (20)

5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptx
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a Paragraph
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptx
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
 

antiplatelet effect of aspirin

  • 1. The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease Heart 2010;96:368-71 Presented by : DR AFIA SALEEM
  • 2. Introduction Aspirin is the mainstay of secondary antithrombotic treatment Aspirin treatment carries a risk of dyspepsia and upper gastrointestinal bleeding Often combined with PPIS
  • 3. PPIs exert their antacid effect by inhibiting the H+/K+exchanging ATPase of the gastric parietal cells Raising intragastric PH Under physiologic acidic conditions,asprin is absorbed in lipid state by passive diffusion across membrane
  • 4. Increased PH cause reduction in Lipophilicity of aspirin Compromises bioavailability and Efficacy of Aspirin Soluble serum P-selectin (sP-selectin) is regarded a marker of platelet activation. TxB2 is regarded as the most specific test for measuring the inhibitory effect of aspirin on platelets
  • 5. Objectives The main purpose of this study was to investigate whether patients with coronary artery disease (CAD) treated with PPI had a reduced platelet response aspirin, as shown by increased residual platelet aggregation and platelet activation, compared with patients with CAD not taking PPIs
  • 6. Study population Patients 418 stable patients with CAD, 54 of whom were treated with PPIs. All patients were treated with non-enteric coated aspirin 75 mg/day and received no other antithrombotic drugs . Study Design Case control study
  • 7. INCLUSION CRITERIA Patients ≥18 years of age with angiographically verified CAD receiving low-dose (75 mg) non-enteric coated aspirin treatment were included in the study EXCLUSION CRITERIA . 1. aspirin intolerance, 2 .any acute or chronic disease (apart from CAD), 3. use of anticoagulants or any drugs known to affect platelet function (including clopidogrel and non-steroidal anti-inflammatory drugs), 4. Pregnancy 5, gastrointestinal bleeding within the past month 6, platelet count <120×109/l 7. any ischaemic event or revascularisation procedures (percutaneous coronary intervention or coronary artery bypass grafting) within the previous 12 months . 8 inability to give informed consent
  • 8. Main outcome measures Platelet aggregation was measured by multiplate((Dynabyte, Munich, Germany) whole blood aggregometry induced by arachidonic acid 1 .0 mmol/l and expressed as Area under aggregation curve(aggregation units *min) Platelet activation was assessed by soluble serum P- selectin. Compliance was confirmed by serum thromboxane B2 levels.
  • 14. Effects on S-TxB2 Levels (Compliance). Subjects S-TxB2 levels Geometric mean Range(ng/ml) Healthy subjects 327+/-123 - No PPI with Aspirin 0.04-18.18 0.96(95%CI 0.88 to 1.05) PPI with Aspirin 0.84-1.01 1.29(95%CI 0.96 to 1.72)
  • 15. Conclusion Patients with CAD treated with PPIs had a reduced response to aspirin, as shown by increased residual platelet aggregation and platelet activation, compared with patients with CAD not taking PPIs. Concomitant use of aspirin and PPIs might leave patients at an increased risk of thrombotic events. These findings may affect the clinical practice of antithrombotic treatment. In view of the widespread use of PPIs, a randomised double-blind crossover study (PPI vs placebo + aspirin) is needed to explore further the inhibitory effect of PPIs on aspirin.